SCHEMBL4564855

SCHEMBL4564855

C=CCC1=CCOc2ccccc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
PKM P14618 1/20 0.35
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
TOP2A P11388 1/20 0.32
ADRA1D P25100 2/20 0.32
ADRA1A P35348 2/20 0.32
ADRA1B P35368 1/20 0.32
MAOB P27338 3/20 0.31
HRH1 P35367 3/20 0.31
KCNH2 Q12809 2/20 0.31
HTR2B P41595 2/20 0.31
ALDH1A1 P00352 2/20 0.31
SLC22A1 O15245 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL295321 0.80 PKM (0.38) TSHRPKMMAOBLMNAKMT2A
SCHEMBL6435548 0.80 PKM (0.33) TSHRPKM
SCHEMBL9772845 0.80 PKM (0.33) TSHRPKMMAOBMEN1KMT2A
SCHEMBL293833 0.77 PKM (0.36) TSHRPKMMAOBKMT2AABCG2
SCHEMBL9768971 0.77 PKM (0.38) TSHRPKMMAOBADRA2ASIGMAR1
SCHEMBL9724429 0.77 PKM (0.38) TSHRPKMMAOBALDH1A1LMNA
SCHEMBL25718526 0.77 TSHR (0.38) TSHRPKMCYP1A2MAPTADRA1D
Hydrochloric Acid SCHEMBL15054537 0.75 PKM (0.37) TSHRPKMMAOBALDH1A1LMNA
SCHEMBL293784 0.75 PKM (0.34) TSHRPKM
SCHEMBL8309740 0.74 PKM (0.36) TSHRPKMMAOBKMT2AABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534801-B2 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands WYETH (US) 2009-05-19 US disclosed
US-20050107431-A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands WYETH (US) 2005-05-19 US disclosed
WO-2005037830-A1 PIPERIDINYLCHROMEN-6-YLSULFONAMIDE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107431-A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, TPH1 TSHR 295/4885PKM 1845/4885CYP1A2 1092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.